STEP - Standardized assessment of elderly people in primary care;STEP - Europäische leitlinie für das standardisierte evidenzbasierte präventive assessment älterer menschen in der medizinischen primärversorgung

Deutsche Medizinische Wochenschrift

Volumn 129, Issue SUPPL. 4, 2004, Pages

  Sandholzer, H ^a   Hellenbrand, W ^b   Renteln Kruse, W ^b   Van Weel, C ^b   Walker, P ^b  

^a Selbstandige Abt F A   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ALCOHOL CONSUMPTION; CHRONIC DISEASE; CONSENSUS; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DYSPNEA; EUROPE; EXERCISE; FALLING; FECES INCONTINENCE; GENERAL PRACTITIONER; GERIATRICS; HEALTH PROGRAM; HEARING IMPAIRMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HYPERTENSION; IMMUNIZATION; INSOMNIA; ISCHEMIC HEART DISEASE; MENTAL FUNCTION; OSTEOARTHRITIS; OSTEOPOROSIS; PAIN; PATIENT ATTITUDE; PERIPHERAL VASCULAR DISEASE; PHYSICAL CAPACITY; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PRIMARY MEDICAL CARE; REVIEW; SMOKING; STROKE; THYROID DISEASE; TRANSIENT ISCHEMIC ATTACK; URINE INCONTINENCE; VISUAL IMPAIRMENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; CONSENSUS; EUROPE; EVIDENCE-BASED MEDICINE; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; PREVENTIVE MEDICINE; PRIMARY HEALTH CARE; REFERENCE STANDARDS; RISK FACTORS;

EID: 11144278639     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-836107     Document Type: Review

References (382)

1. Taylor RC, Buckley EG. Preventive Care of the Elderly: a review of current developments. Occasional Paper 1987; 35
2. Williams EI, Buckley EG, Freer C. Care of Old People: a framework for progress. Occas Pap R Coll Gen Pract 1990; 45
3. Williams EI, Wallace P. Health Checks for People aged 75 and Over. Occas Pap R Coll Gen Pract 1993; 59
4. van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998; 51: 367-375
5. Kempen GI, Miedema I, van den Bos GA, Ormel J. Relationship of domain-specific measures of health to perceived overall health among older subjects. J Clin Epidemiol 1998; 51: 11-18
6. Covinsky KE, Wu AW, Landefeld CS, Jr. Connors AF, Phillips RS, Tsevat J, Dawson NV, Lynn J, Fortinsky RH. Health status versus quality of life in older patients: does the distinction matter? Am J Med 1999; 106: 435-440
7. Fletcher R, Fletcher S, Wagner E. Klinische Epidemiologie: Grundlagen und Anwendung. Ullstein Medical Wiesbaden, München, 1999
8. Chew CA, Wilkin D, Glendinning C. Annual assessments of patients aged 75 years and over: views and experiences of elderly people. Br J Gen Pract 1994; 44: 567-570
9. Chew CA, Wilkin D, Glendenning C. Annual assessment of patients aged 75 years and over: general practitioners' and practice nurses' views and experiences. Br J Gen Pract 1994; 44: 263-267
10. National Service Framework for Older People. Department of Health UK, Available from DOH website://www.doh.gov.uk/nsf/older people/htm Ref Type: Data File. 2001
11. ww.cordis.lu/en/home.html, Ref Type: Data File. 2003
12. Standardised Assessment for Elderly People in Primary Care in Europe. Final Report to the European Commission, 1998
13. Philp I. EASY-Care: A systematic approach to the assessment of older people. Geriatric Medicine 2000; 30: 15-19
14. Williams EI. A model to describe social performance levels in elderly patients. J Roy Col Gen Pract 1986; 36: 422-423
15. De Backer G, Myny K, De Henauw S, Doyen Z, Van Oyen H, Tafforeau J, Kornitzer M. Prevalence, awareness, treatment and control of arterial hypertension in an elderly population in Belgium. J Hum Hypertens 1998; 12: 701-706
16. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998; 16: 747-752
17. Kannel WB, Gordon T. Evaluation of cardiovascular risk in the elderly: The Framingham Study. Bull NY Acad Med 1978; 54: 573-579
18. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens 1993; 15: 967-978
19. Pearce K, Furberg C, Rushing J. Antihypertensive drugs decrease mortality, coronary events, and stroke in elderly persons. Evidence-Based Medicine 1996; 1: 105
20. Sanderson S. Hypertension in the elderly: pressure to treat? Health Trends 1996; 28: 117-121
21. Mulrow C, Lau J, Cornell J, Brand M. Pharmacotherapy for hypertension in the elderly (Cochrane Review). The Cochrane Library 1999
22. Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly: Implications and generalizability of randomized trials. JAMA 1994; 272: 1932-1938
23. Gueyffier F, Bulpitt C, Boissel JP, Schron E, Ekbom T, Fagard R, Casiglia E, Kerlikowske K, Coope J INDANA Group. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. Lancet 1999; 353: 793-796
24. WHO-ISH Hypertension Guidelines Committee. International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183
25. Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, Poulter NR, Russell G. British Hypertension Society guidelines for hypertension management 1999: summary. BMJ 1999; 319: 630-635
26. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762
27. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR. The J-curve phenomenon and the treatment of hypertension: Is there a point beyond which pressure reduction is dangerous? JAMA 1991; 265: 489-495
28. Wood D, Durrington P, Mclnnes G et al. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80: S1-S29(Suppl 2
29. de Bruyne MC, Mosterd A, Hoes AW, Kors JA, Kruijssen DA, van Bemmel JH, Hofman A, Grobbee DE. Prevalence, determinants, and misclassification of myocardial infarction in the elderly. Epidemiology 1997; 8: 495-500
30. Jonsdottir LS, Sigfusson N, Sigvaldason H, Thorgeirsson G. Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study. Eur Heart J 1998; 19: 1011-1018
31. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM. Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ 1998; 316: 1430-1434
32. Rosengren A, Wilhelmsen L, Hagman M, Wedel H. Natural history of myocardial infarction and angina pectoris in a general population sample of middle-aged men: a 16-year follow-up of the Primary Prevention Study, Goteborg, Sweden. J Intern Med 1998; 244: 495-505
33. Walker MK, Whincup PH, Shaper AG, Lennon LT, Thomson AG. Validation of patient recall of doctor-diagnosed heart attack and stroke: a postal questionnaire and record review comparison. Am J Epidemiol 1998; 148: 355-361
34. Antiplatelet Trialists Collaboration. Collaborative overview of randomized trials of antiplatelet therapy. 1.Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 208: 81-106
35. Goldstein RE, Andrews M, Hall WJ, Moss AJ Multicenter Myocardial Ischemia Research Group. Marked reduction in long-term cardiac deaths with aspirin after a coronary event. J Am Coll Cardiol 1996; 28: 326-330
36. Frishman WH, Cheng A. Secondary prevention of myocardial infarction: role of beta-adrenergic blockers and angiotensin-converting enzyme inhibitors. Am Heart J 1999; 137: S25-S34
37. Hall AS, Ball SG. ACE-inhibitor therapy after myocardial infarction - a new treatment strategy. Z Kardiol 1994; 83: 57-62(Suppl 4
38. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-153
39. Tonkin A The Long-Term Intervention with Pravastatin in Ischämic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-1357
40. Borghi C, Ambrosioni E. Primary and secondary prevention of myocardial infarction. Clinical Exp Hypertens 1996; 18: 547-558
41. Tervahauta M, Pekkanen J, Nissinen A. Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease. Finnish cohorts of the Seven Countries Study. J Am Coll Cardiol 1995; 26: 1623-1629
42. Malmberg K DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997; 314: 1512-1515
43. Aronow W. Management of older persons after myocardial infarction. JAGS 1998; 46: 1459-1468
44. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-613
45. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Jr. Smith EE, Weaver WD. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28: 1328-1428
46. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, III. Smith EE, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Jr. Garson A, Gregoratos G, Ryan TJ, Jr. Smith SC. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999; 34: 890-911
47. De Bono D, Hopkins A. The management of acute myocardial infarction: guidelines and audit standards. Report of a Workshop of the Joint Audit Committee of the British Cardiac Society and the Royal College of Physicians. J R Coll Phys 1994; 28: 312-317
48. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352: 1167-1171
49. Lip GY, Golding DJ, Nazir M, Beevers DG, Child DL, Fletcher RI. A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J Gen Pract 1997; 47: 285-289
50. Sudlow M, Rodgers H, Kenny RA, Thomson R. Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ 1997; 314: 1529-1530
51. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000; 160: 41-46
52. Aronow W. Management of the older person with atrial fibrillation. JAGS 1999; 47: 740-748
53. Ezekowitz MD, Levine JA. Preventing stroke in patients with atrial fibrillation. JAMA 1999; 281: 1830-1835
54. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-1457
55. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131: 492-501
56. Nelson KM, Talbert RL. Preventing stroke in patients with nonrheumatic atrial fibrillation. Am J Hosp Pharm 1994; 51: 1175-1183
57. Hart RG, Sherman DG, Easton JD, Cairns JA. Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology 1998; 51: 674-681
58. Quality Standards Sub-Committee of the American Academy of Neurology. Stroke prevention in patients with non-valvular atrial fibrillation. Neurology 1998; 51: 671-673
59. Levy S, Breithardt G, Campbell RW, Camm AJ, Daubert JC, Allessie M, Aliot E, Capucci A, Cosio F, Crijns H, Jordäns L, Hauer RN, Lombardi F, Luderitz B. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 1998; 19: 1294-1320
60. Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander L, Rader D, Ross JL, Raps E, Ozer MN, Brass LM, Malone ME, Goldberg S, Booss J, Hanley DF, Toole JF, Greengold NL, Rhew DC. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 1999; 281: 1112-1120
61. Nademanee K, Kosar EM. Long-term antithrombotic treatment for atrial fibrillation. Am J Cardiol 1998; 82: 37N-42N
62. Akhtar W, Reeves WC, Movahed A. Indications for anticoagulation in atrial fibrillation. Am Fam Physician 1998; 58: 130-136
63. Lip GY, Lowe GD. ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation. BMJ 1996; 312: 45-49
64. Rodeheffer RJ, Jacobsen SJ, G ersh BJ, Kottke TE, McCann HA, Bailey KR, Ballard DJ. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 1993; 68: 1143-1150
65. McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, Dargie HJ. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829-833
66. Yamani M, Massie BM. Congestive heart failure: insights from epidemiology, implications for treatment. Mayo Clin Proc 1993; 68: 1214-1218
67. Davie AP, Francis CM, Love MP, Caruana L, Starkey IR, Shaw TR, Sutherland GR, McMurray JJ. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996; 312: 222
68. McMurray JV, McDonagh TA, Davie AP et al. Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure? Eur Heart J 1998; 9: 842-846
69. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995; 273: 1450-1456
70. Morgan S, Smith H, Simpson I, Liddiard GS, Raphäl H, Pickering RM, Mant D. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey. BMJ 1999; 318: 368-372
71. Effect of Enalopril on Mortality and the Development of Heart Failure in Asymptomatic Patients with reduced Left Ventricular Ejection Fractions. N Engl J Med 1992; 327: 685-691
72. Smith H, Pickering RM, Struthers A, Simpson I, Mant D. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ 2000; 320: 906-908
73. Tresch DD, Aronow WS. Clinical manifestations and diagnosis of coronary artery disease. Clin Geriatr Med 1996; 12: 89-100
74. Dewhurst G, Wood DA, Walker F, Lampe FC, Jeffreys M, Cooper M, Williams JD. A population survey of cardiovascular disease in elderly people: design, methods and prevalence results. Age Ageing 1991; 20: 353-360
75. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999; 353: 89-92
76. Bottomley A. Methodology for assessing the prevalence of angina in primary care using practice based information in northern England. J Epidemiol Community Health 1997; 51: 87-89
77. Kannel WB. Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure. Cardiovasc Drugs Ther 1997; 11: 199-212(Suppl 1
78. Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM, Squair JL. Secondary prevention clinics for coronary heart disease: randomised trial of effect on health. BMJ 1998; 316: 1434-1437
79. BMJ Publishing Group. Clinical Evidence: A compendium of best available evidence for effective health care. London. Ref Type: Data File, 2000
80. Agner E. Natural history of angina pectoris, possible previous myocardial infarction and intermittent claudication during the eighth decade. A longitudinal epidemiologic study. Acta Med Scand 1981; 210: 271-276
81. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18: 185-192
82. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60 year old men and women. J Chron Dis 1981; 34: 261-269
83. Vogt M, McKenna M, Anderson S et al. The relationship between ankle-arm index and mortality in older men and women. JAGS 1993; 41: 523-530
84. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol 1992; 45: 529-542
85. Fowkes FG. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol 1988; 17: 248-254
86. Quick C, Cotton L. The measured effect of stopping smoking on intermittent claudication. Br J Surg 1982; 69 (Suppl): 524-526
87. Leng G, Fowler B, Ernst E. Exercise for intermittent claudication (Cochrane Review). The Cochrane Library 2000
88. US Preventive Services task Force. Guide to clinical preventive services. PA: Lippincott, Williams and Wilkins, Philadelphia, 1996
89. Bamford J, Sandercock P, Dennis M, Warlow C, Jones L, McPherson K, Vessey M, Fowler G, Molyneux A, Hughes T. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 1988; 51: 1373-1380
90. Anderson CS, Jamrozik KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG. Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989-1990. Med J Aust 1993; 158: 80-84
91. Sacco RL. Identifying patient populations at high risk for stroke. Neurology 1998; 51: S27-S30
92. Mead GE, Murray H, McCollum CN, O'Neill PA. How do general practitioners manage patients at risk from stroke? Br J Clin Pract 1996; 50: 426-430
93. Albers GW, Tijssen JG. Antiplatelet therapy: new foundations for optimal treatment decisions. Neurology 1999; 53: S25-S31
94. Tijssen JG. Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results. Neurology 1998; 51: S15-S16
95. Sacco RL, Elkind MS. Update on antiplatelet therapy for stroke prevention. Arch Intern Med 2000; 160: 1579-1582
96. Wilterdink JL, Easton JD. Dipyridamole plus aspirin in cerebrovascular disease. Arch Neurol 1999; 56: 1087-1092
97. Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: A statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Stroke 1999; 30: 2502-2511
98. Liu M, Counsell C, Sanderock P. Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack. The Cochrane Library 2000
99. Koudstaal P. Secondary prevention following stroke or transient ischaemic attack in patients with non-rheumatic atrial fibrillation: anti-coagulant versus antiplatelet therapy. Stroke Module of the Cochrane Database of Systematic Reviews ( updated 2 December 1996), In Warlow C, Van Gijn J, Sandercock P (eds). 1997
100. Croxson SC, Burden AC, Bodington M, Botha JL. The prevalence of diabetes in elderly people. Diabet Med 1991; 8: 28-31
101. Wareham NJ, O'Rahilly S. The changing classification and diagnosis of diabetes. New classification is based on pathogenesis, not insulin dependence. BMJ 1998; 317: 359-360
102. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Non-insulin dependent diabetes mellitus and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 3: 960-967
103. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713
104. Tasker PRW. The role of the general practitioner in the care of the elderly diabetic patient. John Wiley and Sons Ltd, Chister, In Finucane P, Sinclair A (eds) Diabetes in Old Age. 1995: 255-267
105. Paterson KR. Population screening for diabetes mellitus. Professional Advisory Committee of the British Diabetic Association. Diabet Med 1993; 10: 777-781
106. Falkenberg M, Kagedal B, Norr A. Screening of an elderly female population for hypo- and hyperthyroidism by use of a thyroid hormone panel. Acta Med Scand 1983; 214: 361-365
107. Brochmann H, Bjoro T, Gaarder P et al. Prevalence of thyroid dysfunction in elderly subjects. Acta Endocrin 1998; 117: 7-12
108. Okamura K, Ueda K, Sone H et al. A sensitive thyroid stimulating hormone assay for screening of thyroid functional disorder in elderly Japanese. JAGS 1989; 37: 3178-3182
109. Knudsen N, Jorgensen T, Rasmussen S et al. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol 1999; 51: 361-367
110. Helfand M, Redfern CC. Clinical guideline, part 2. Screening for thyroid disease: an update. American College of Physicians. Ann Intern Med 1998; 129: 144-158
111. Weetman AP. Hypothyroidism: screening and subclinical disease. BMJ 1997; 314: 1175-1178
112. Tanis B, Westendorp G, Smelt H. Effect of thyroid sustitution on hypercholesterolaemia in patients with sub-clinical hypothyroidism: a reanalysis of intervention studies. Clin Endocrinol 1996; 44: 643-649
113. Nystrom E, Caidahl K, Fager G et al. A double-blind cross-over 12 month study of L-thyroxine treatment of women with sub-clinical hypothyroidism. Endocrinology 1988; 29: 63-76
114. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med 1984; 101: 18-24
115. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, Smith SA, Daniels GH, Cohen HD. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160: 1573-1575
116. Candian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care. Canada Communication Group, Toronto, 1994
117. US Preventive Services task Force. Guide to Clinical Preventive Services. MD: Williams and Wilkins, Baltimore, 1996
118. American College of Physicians. Clinical guideline, part 1. Screening for thyroid disease. Ann Intern Med 1998; 129: 141-143
119. Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology. BMJ 1996; 313: 539-544
120. Luepker RV, Mo JP. Treatment of hypercholesterolemia in the elderly: is cholesterol a risk factor and should it be treated? Coron Artery Dis 1993; 4: 605-610
121. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389
122. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009
123. Evans PH. The primary prevention of coronary heart disease with statins: practice headache or public health? Br J Gen Pract 2000; 50: 695-697
124. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307
125. Publishing Group. Joint British Recommendations on Prevention of Coronary Heart Disease in Clincal Practice. BMJ Heart 1998 (80)(Supplement to December)
126. Winder AF. Management of lipids in the elderly. J Roy Soc Med 1998; 91: 189-191
127. Hippisley-Cox J, Pringle M. The cost-effectiveness of lipid lowering in patients with ischaemic heart disease: an intervention and evaluation in primary care. Br J Gen Pract 2000; 50: 699-705
128. Scottish Intercollegiate Guidelines Network (SIGN). Lipids and the primary prevention of coronary heart disease. A national clinical guideline. Number 40. Edinburgh, SIGN. Ref Type: Data File, 1999
129. Scottish Intercollegiate Guidelines Network(SIGN). Secondary prevention of coronary heart disease after myocardial infarction. A national clinical guideline. Number 41. Edinburgh, SIGN. Ref Type: Data File, 2000
130. WHO. Assessment of Fracture Risk and its Application for Screening for Post-menopausal Osteoporosis. WHO, Geneva, WHO Technical Report, Series 843. 1994
131. Silver JJ, Einhorn TA. Osteoporosis and aging: Current update. Clin Orthop 1995: 10-20
132. Royal College of Physicians. Osteoporosis: Clinical Guidelines for the Prevention and Treatment. Royal College of Physicians, London, 1999
133. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 1994; 308: 1081-1082
134. Lauritzen JB, Petersen MM, Lund B. Effect of external hip protectors on hip fractures. Lancet 1993; 341: 11-13
135. Wallace RB, Ross JE, Huston JC, Kundel C, Woodworth G. Iowa FICSIT trial: the feasibility of elderly wearing a hip joint protective garment to reduce hip fractures. J Am Geriatr Soc 1993; 41: 338-340
136. Department of Health. Quick Reference Primary Care Guide on Prevention and Treatment of Osteoporosis. Department of Health, London, 1998
137. Verbrugge LM, Gates DM, Ike RW. Risk factors for disability among US adults with arthritis. J Clin Epidemiol 1991; 44: 167-182
138. Vetter NJ, Charny M, Lewis PA, Farrow S. Prevalence and treatment of symptoms of rheumatism and arthritis among over 65 year olds: a community profile. Br J Gen Pract 1990; 40: 69-71
139. Dieppe PA, Cushnaghan J, Shepstone L. The Bristol 'OA500' study: progression of osteoarthritis (OA) over 3 years and the relationship between clinical and radiographic changes at the knee joint. Osteoarthritis Cartilage 1997; 5: 87-97
140. Kempen GI, Ormel J, Brilman EI, Relyveld J. Adaptive responses among Dutch elderly: the impact of eight chronic medical conditions on health-related quality of life. Am J Public Health 1997; 87: 38-44
141. Tugwell P. Economic evaluation of the management of pain in osteoarthritis. Drugs 1996; 52: 48-58(Suppl 3
142. Sun Y, Gunther KP, Brenner H. Reliability of radiographic grading of osteoarthritis of the hip and knee. Scand J Rheumatol 1997; 26: 155-165
143. Sun Y, Sturmer T, Gunther KP, Brenner H. Reliability and validity of clinical outcome measurements of osteoarthritis of the hip and knee - a review of the literature. Clin Rheumatol 1997; 16: 185-198
144. O'Reilly SC, Muir KR, Doherty M. Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial. Ann Rheum Dis 1999; 58: 15-19
145. van Baar ME, Dekker J, Oostendorp RA, Bijl D, Voorn TB, Lemmens JA, Bijlsma JW. The effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a randomized clinical trial. J Rheumatol 1998; 25: 2432-2439
146. Sullivan T, Allegrante JP, Peterson MG, Kovar PA, MacKenzie CR. One-year followup of patients with osteoarthritis of the knee who participated in a program of supervised fitness walking and supportive patient education. Arthritis Care Res 1998; 11: 228-233
147. Rogind H, Bibow-Nielsen B, Jensen B, Moller HC, Frimodt-Moller H, Bliddal H. The effects of a physical training program on patients with osteoarthritis of the knees. Arch Phys Med Rehabil 1998; 79: 1421-1427
148. Roush MB, Sevier TL, Wilson JK, Jenkinson DM, Helfst RH, Gehlsen GM, Basey AL Anterior knee pain: a clinical comparison of rehabilitation methods. Clin J Sport Med 2000; 10: 22-28
149. Maurer BT, Stern AG, Kinossian B, Cook KD, Jr. Schumacher HR. Osteoarthritis of the knee: isokinetic quadriceps exercise versus an educational intervention. Arch Phys Med Rehabil 1999; 80: 1293-1299
150. Riedemann PJ, Bersinic S, Cuddy LJ, Torrance GW, Tugwell PX. A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: a meta-analysis. J Rheumatol 1993; 20: 2095-2103
151. Zhao SZ, McMillen JI, Markenson JA, Dedhiya SD, Zhao WW, Osterhaus JT, Yu SS. Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib. Pharmacotherapy 1999; 19: 1269-1278
152. Brune K, Kalden J, Zacher J, Zeilhofer HU. Selective inhibitors of Cyclooxygenase 2. Deutsches Ärzteblatt 2000; 97: 1818-1825
153. Dieppe P, Chard J, Faulkner A, Lohmander S. Osteoarthritis. Clinical Evidenced compendium of the best available evidence for effective health care. BMJ Publishing Group, London, 2000
154. Siegmeth W, Krepelka M, Supper A. [Intra-articular injections in arthrosis of the small and medium size joints]. Wien Med Wochenschr 1995; 145: 117-119
155. Callahan CM, Drake BG, Heck DA, Dittus RS. Patient outcomes following tricompartmental total knee replacement. A meta-analysis. JAMA 1994; 271: 1349-1357
156. Norman-Taylor FH, Palmer CR, Villar RN. Quality-of-life improvement compared after hip and knee replacement. J Bone Joint Surg Br 1996; 78: 74-77
157. White EF, Mulley GP. Footcare for very elderly people: A community survey. Age Ageing 1989; 18: 275-278
158. Vetter NJ, Jones DA, Victor CR. A health visitor affects the problems others do not reach. Lancet 1986; ii: 30-32
159. Shereff MJ. Geriatric foot disorders: how to avoid undertreating them. Geriatrics 1987; 42: 69-80
160. Gordon GM, Cuttic MM. Exercise and the aging foot. South Med J 1994; 87: S36-S41
161. Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in defintion, population characteristics and study type. JAGS 1998; 46: 473-480
162. Harrison GL, Memel DS. Urinary incontinence in women: its prevalence and its management in a health promotion clinic. Br J Gen Pract 1994; 44: 149-152
163. Wyman J, Harkins S, Fantl A. Psychosocial impact of urinary incontinence in the community-dwelling population. JAGS 1990; 38: 282-288
164. Amundsen C, Lau M, English SF, McGuire EJ. Do urinary symptoms correlate with urodynamic findings? J Urol 1999; 161: 1871-1874
165. Seim A, Hermstad R, Hunskaar S. Female urinary incontinence: long-term follow-up after treatment in general practice. Br J Gen Pract 1998; 48: 1731-1734
166. Wells T. Pelvic (floor) muscle exercise. JAGS 1990; 38: 333-337
167. Burgio K, Engel B. Biofeedback-assisted behavioral training for elderly men and women. JAGS 1990; 38: 338-340
168. Roe B, Williams K, Palmer M. Bladder training for urinary incontinence (Cochrane Review). The Cochrane Library 1999
169. Eustice S, Roe B, Paterson J. Prompted voiding for the management of urinary incontinence in adults (Cochrane Review). The Cochrane Library 2000
170. Andersson KE. Treatment of overactive bladder: other drug mechanisms. Urology 2000; 55: 51-57
171. Wein A. Pharmacologic treatment of incontinence. JAGS 1990; 38: 317-325
172. Thuroff JW, Chartier-Kastler E, Corcus J, Humke J, Jonas U, Palmtag H, Tanagho EA. Medical treatment and medical side effects in urinary incontinence in the elderly. World J Urol 1998; 16 (Suppl 1): S48-S61
173. Glazener CMA, Cooper K. Anterior vaginal repair for urinary incontinence in women (Cochrane Review). The Cochrane Library 2000
174. Sultana CJ, Campbell JW, Pisanelli WS, Sivinski L, Rimm AA. Morbidity and mortality of incontinence surgery in elderly women: an analysis of Medicare data. Am J Obstet Gynecol 1997; 176: 344-348
175. Romero Y, Evans JM, Fleming KC, Phillips SF. Constipation and fecal incontinence in the elderly population. Mayo Clin Proc 1996; 71: 81-92
176. Whitehead WE, Burgio KL, Engel BT. Biofeedback treatment of fecal incontinence in geriatric patients. J Am Geriatr Soc 1985; 33: 320-324
177. Iliffe S, Haines A, Gallivan S, Booroff A, Goldenberg E, Morgan P. Assessment of elderly people in general practice. 2. Functional abilities and medical problems. Br J Gen Pract 1991; 41: 13-15
178. Freer CB. Screening the elderly. BMJ 1990; 300: 1447-1448
179. Hellenbrand W, Vieregge P, Robra BP, Nischan P, Glass J, Haagen P, Jorg J, Oertel WH, Schneider E, Ulm G. [Etiology of Parkinson disease. An epidemiologic perspective with possible implications for prevention]. Nervenarzt 1993; 64: 770-786
180. Clarke CE. Does levodopa therapy delay death in Parkinson's disease? A review of the evidence. Mov Disord 1995; 10: 250-256
181. Szecsenyi J, Sandholzer H. Hearing disorders in general practice. A study on prevalence and validity of screening tests in 560 patients. Kilian Verlag, Marburg, 1995
182. Karlsmose B, Lauritzen T, Parving A. Prevalence of hearing impairment and
183. Sandholzer H. Ambulatory geriatric care. Prevalence of impairment and disability, provision of care, risk factors of poor outcome and value of geriatric assessment. Hannover: Hannover Medical School, 1999
184. Mulrow CD, Aguilar C, Endicott JE, Tuley MR, Velez R, Charlip WS, Rhodes MC, Hill JA, DeNino LA. Quality-of-life changes and hearing impairment. A randomized trial. Ann Intern Med 1990; 113: 188-194
185. Stephens SD, Callaghan DE, Hogan S, Meredith R, Rayment A, Davis AC. Hearing disability in people aged 50-65: effectiveness and acceptability of rehabilitative intervention. BMJ 1990; 300: 508-511
186. van den Berg PJ, Prins A, Verschuure H, Hoes AW. Effectiveness of a single and a repeated screen for hearing loss in the elderly. Audiology 1999; 38: 339-340
187. Macphee GJ, Crowther JA, McAlpine CH. A simple screening test for hearing impairment in elderly patients. Age Ageing 1988; 17: 347-351
188. van Schaik V, Horchner C, Bartelink M et. al. Value of a four item questionnaire in the diagnosis of presbyacusis. Europ J Gen Pract 1997; 3: 62-64
189. Weih LM, VanNewkirk MR, McCarty CA, Taylor HR. Age-specific causes of bilateral visual impairment. Arch Ophthalmol 2000; 118: 264-269
190. Elliott DB, Patla AE, Furniss M, Adkin A. Improvements in clinical and functional vision and quality of life after second eye cataract surgery. Optom Vis Sci 2000; 77: 13-24
191. Tielsch JM, Sommer A, Witt K, Katz J, Royall RM. Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol 1990; 108: 286-290
192. Arnold JJ, Sarks SH. Age Related Macular Degeneration. Clinical evidenced compendium of the best available evidence for effective health care. BMJ Publishing Group, London, 2000
193. Wormald RP, Wright LA, Courtney P, Beaumont B, Haines AP. Visual problems in the elderly population and implications for services. BMJ 1992; 304: 1226-1229
194. Long CA, Holden R, Mulkerrin E, Sykes D. Opportunistic screening of visual acuity of elderly patients attending outpatient clinics. Age Ageing 1991; 20: 392-395
195. Smeeth L, Iliffe S. Effectiveness of screening older people for impaired vision in community setting: systematic review of evidence from randomised controlled trials. BMJ 1998; 316: 660-663
196. Kay E, Locker D. A systematic review of the effectiveness of health promotion aimed at improving oral health. Community Dent Health 1998; 15: 132-144
197. Stiefel DJ, Truelove EL, Chin MM, Mandel LS. Efficacy of chlorhexidine swabbing in oral health care for people with severe disabilities. Spec Care Dentist 1992; 12: 57-62
198. Simons D, Kidd EA, Beighton D, Jones B. The effect of chlorhexidine/xylitol chewing-gum on cariogenic salivary microflora: a clinical trial in elderly patients. Caries Res 1997; 31: 91-96
199. Erickson L. Oral health promotion and prevention for older adults. Dent Clin North Am 1997; 41: 727-750
200. Steele JG, Walls AW, Ayatollahi SM, Murray JJ. Major clinical findings from a dental survey of elderly people in three different English communities. Br Dent J 1996; 180: 17-23
201. Shay K, Ship JA. The importance of oral health in the older patient. J Am Geriatr Soc 1995; 43: 1414-1422
202. Steele JG, Walls AW, Ayatollahi SM, Murray JJ. Dental attitudes and behaviour among a sample of dentate older adults from three English communities. Br Dent J 1996; 180: 131-136
203. Hujoel PP, Powell LV, Kiyak HA. The effects of simple interventions on tooth mortality: findings in one trial and implications for future studies. J Dent Res 1997; 76: 867-874
204. Fiske J, G elbier S, Watson RM. The benefit of dental care to an elderly population assessed using a sociodental measure of oral handicap. Br Dent J 1990; 168: 153-156
205. Horsley JR, Sterling IJ, Waters WE, Howell JB. Respiratory symptoms among elderly people in the New Forest area as assessed by postal questionnaire. Age Ageing 1991; 20: 325-331
206. Brattberg G, Parker MG, Thorslund M. A longitudinal study of pain: reported pain from middle age to old age. Clin J Pain 1997; 13: 144-149
207. Fischer G. The Ages Trial. Norddeutscher Forschungsverbund Public Health, Hannover, 1997
208. Murt H, Parsons PE, Harlan WR et al. Disability, utilization, and costs associated with musculoskeletal conditions. Natl Med Care Unit Expend Surv 1986: C 1-64
209. Caraceni A. Clinicopathologic correlates of common cancer pain syndromes. Hematol Oncol Clin North Am 1996; 10: 57-78
210. Twycross RG. The management of pain in cancer: a guide to drugs and dosages. Oncology (Huntingt) 1988; 2: 35-44, 47
211. Onghena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992; 49: 205-219
212. Ventafridda V, Bianchi M, Ripamonti C, Sacerdote P, De Conno F, Zecca E, Panerai AE. Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man. Pain 1990; 43: 155-162
213. The management of chronic pain in older persons. AGS Panel on Chronic Pain in Older Persons. American Geriatrics Society. Geriatrics 1998; 53: S8-24((Suppl 3)
214. Eccles M, Freemantle N, Mason J The North of England Non-Steroidal Anti-Inflammatory Drug Guideline Development Group. North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. BMJ 1998; 317: 526-530
215. Whitecar PS, Jonas AP, Clasen ME. Managing pain in the dying patient. Am Fam Physician 2000; 61: 755-764
216. Du Pen SL, Du Pen AR, Polissar N, Hansberry J, Kraybill BM, Stillman M, Panke J, Everly R, Syrjala K. Implementing guidelines for cancer pain management: results of a randomized controlled clinical trial. J Clin Oncol 1999; 17: 361-370
217. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 1995; 63: 65-76
218. Becker N, Sjogren P, Bech P, Olsen AK, Eriksen J. Treatment outcome of chronic non-malignant pain patients managed in a danish multidisciplinary pain centre compared to general practice: a randomised controlled trial. Pain 2000; 84: 203-211
219. Morgan K, Clarke D. Longitudinal trends in late-life insomnia: implications for prescribing. Age Ageing 1997; 26: 179-184
220. Newman AB, Enright PL, Manolio TA, Haponik EF, Wahl PW. Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the Cardiovascular Health Study. J Am Geriatr Soc 1997; 45: 1-7
221. Baillargeon L. Behavior and cognitive treatments for insomnia. An alternative to pharmacotherapy. Can Fam Physician 1997; 43: 290-296
222. Hajak G, Muller-Popkes K, Riemann D, Mayer G, Lauer C. Psychological, psychotherapeutic and other non-pharmacologic forms of therapy in treatment of insomnia. Position of the "Insomnia" Study Group of the German Society of Sleep Research and Sleep Medicine. Fortschr Neurol Psychiatr 1997; 65: 133-144
223. King AC, Oman RF, Brassington GS, Bliwise DL, Haskell WL. Moderate-intensity exercise and self-rated quality of sleep in older adults. A randomized controlled trial. JAMA 1997; 277: 32-37
224. Stoppe G, Sandholzer H, Staedt J, Winter S, Kiefer J, Ruther E. Sleep disturbances in the demented elderly: treatment in ambulatory care. Sleep 1995; 18: 844-848
225. Kalmijn S, Curb JD, Rodriguez BL, Yano K, Abbott RD. The association of body weight and anthropometry with mortality in elderly men: the Honolulu Heart Program. Int J Obes Relat Metab Disord 1999; 23: 395-402
226. Ostbye T, Steenhuis R, Wolfson C, Walton R, Hill G. Predictors of five-year mortality in older Canadians: the Canadian Study of Health and Aging. J Am Geriatr Soc 1999; 47: 1249-1254
227. Reynolds MW, Fredman L, Langenberg P, Magaziner J. Weight, weight change, mortality in a random sample of older community-dwelling women. J Am Geriatr Soc 1999; 47: 1409-1414
228. Lehmann AB, Bassey EJ. Longitudinal weight changes over four years and associated health factors in 629 men and women aged over 65. European J Clin Nutr 1995; 50: 6-11
229. Takala JK, Mattila KJ, Ryynanen OP. Overweight, underweight and mortality among the aged. Scand J Prim Health Care 1994; 12: 244-248
230. Thompson MP, Morris LK. Unexplained weight loss in the ambulatory elderly. J Am Geriatr Soc 1991; 39: 497-500
231. The prevention of falls in later life. A report of the Kellogg International Work Group on the Prevention of Falls by the Elderly. Dan Med Bull 1987; 34: 1-24(Suppl 4
232. Nevitt MC. Falls in the elderly: risk factors and prevention. PA: Lippincott-Raven, Philadelphia, In Masdeu JC, Sudarksy L, Wolfson L (eds) Gait disorders of ageing. Falls and therapeutic strategies. 1997: 13-36
233. Dunn JE, Rudberg MA, Furner SE, Cassel CK. Mortality, disability, and falls in older persons: The role of underlying disease and disability. Am J Publ Health 1992; 82: 395-400
234. Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott AM, Hausherr E, Meunier PJ, Breart G. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet 1996; 348: 145-149
235. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319: 1701-1707
236. Ryynanen OP, Kivela SL, Honkanen R. Times, places, and mechanisms of falls among the elderly. Z Gerontol 1991; 24: 154-161
237. Campbell AJ, Reinken J, Allan BC, Martinez GS. Falls in old age: a study of frequency and related clinical factors. Age Ageing 1981; 10: 264-270
238. Blake AJ, Morgan K, Bendall MJ, Dallosso H, Ebrahim SB, Arie TH, Fentem PH, Bassey EJ. Falls by elderly people at home: prevalence and associated factors. Age Ageing 1988; 17: 365-372
239. Campbell AJ, Borrie MJ, Spears GF. Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol Med Sci 1989; 44: M112-M117
240. Campbell AJ, Borrie MJ, Spears GF, Jackson SL, Brown JS, Fitzgerald JL. Circumstances and consequences of falls experienced by a community population 70 years and over during a prospective study. Age Ageing 1990; 19: 136-141
241. King MB, Tinetti ME. Falls in community-dwelling older persons. J Am Geriatr Soc 1995; 43: 1146-1154
242. Renteln-Kruse W. Falls in the elderly and drugs. Z Gerontol Geriatr 1997; 30: 276-280
243. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30-39
244. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999; 47: 40-50
245. Van Weel C, Vermeulen H, BW. Falls, a community care perspective. Lancet 1995; 345: 1549-1551
246. Vellas BJ, Wayne SJ, Romero LJ, Baumgartner RN, Garry PJ. Fear of falling and restriction of mobility in elderly fallers. Age Ageing 1997; 26: 189-193
247. Oakley A, Dawson MF, Holland J et al. Preventing falls and subsequent injury in older people. Quality of Healthcare 1996; 5: 243-249
248. Wagner EH, LaCroix AZ, Grothaus L et al. Preventing disability and falls in older adults: a population-based randomized trial. Am J Publ Health 1994; 84: 1800-1806
249. Hornbrook MC, Stevens VJ, Wingfield DJ, Hollis JF, Greenlick MR, Ory MG. Preventing falls among community-dwelling older persons: results from a randomized trial. Gerontologist 1994; 34: 16-23
250. Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, Roberts SB, Kehayias JJ, Lipsitz LA, Evans WJ. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994; 330: 1769-1775
251. Tinetti ME, Baker DI, McAvay G, Claus EB, Garrett P, Gottschalk M, Koch ML, Trainor K, Horwitz RI. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994; 331: 821-827
252. Province MA, Hadley EC, Hornbrook MC et al. The effects of exercise on falls in elderly patients. J Am Med Ass 1995; 273: 1341-1347
253. Close J, Ellis M, Hooper R, Glucksman E, Jackson S, Swift C. Prevention of falls in the elderly trial (PROFET): a randomised controlled trial. Lancet 1999; 353: 93-97
254. Rait G, Burns A, Chew C. Age, ethnicity, and mental illness: a triple whammy. BMJ 1996; 313: 1347-1348
255. Rait G, Burns A. Appreciating background and culture: the South Asian elderly and mental health. Int J Geriatr Psychiatry 1997; 12: 973-977
256. Rait G, Burns A, Baldwin R, Morley M, Chew-Graham C, St Leger AS, Abas M. Screening for depression in African-Caribbean elders. Fam Pract 1999; 16: 591-595
257. Rait G, Morley M, Burns A, Baldwin R, Chew-Graham C, St Leger AS. Screening for cognitive impairment in older African-Caribbeans. Psychol Med 2000; 30: 957-963
258. Eccles M, Clarke J, Livingstone M, Freemantle N, Mason J. North of England evidence based guidelines development project: guideline for the primary care management of dementia. BMJ 1998; 317: 802-808
259. Hofman A, Rocca WA, Brayne C, Breteler MM, Clarke M, Cooper B, Copeland JR, Dartigues JF, da Silva DA, Hagnell O. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol 1991; 20: 736-748
260. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, Copeland JR, Dartigues JF, Jagger C, Martinez-Lage J, Soininen H, Hofman A. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54: S4-S9
261. Iliffe S, Haines A, Gallivan S, Booroff A, Goldenberg E, Morgan P. Assessment of elderly people in general practice. 1. Social circumstances and mental state. Br J Gen Pract 1991; 41: 9-12
262. Birks JS, Melzer D. Donepezil for mild and moderate Alzheimer's disease (Cochrane Review). The Cochrane Library 2000
263. Birks J, Lakovidou V, Tsolaki M. Rivastigmine for Alzheimer's disease (Cochrane Review). The Cochrane Library 2000
264. Livingston G, Katona C. How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis. Int J Geriatr Psychiatry 2000; 15: 203-207
265. Burns A, Russell E, Page S. New drugs for Alzheimer's disease. Br J Psychiatry 1999; 174: 476-479
266. Stoppe G, Staedt J. Psychopharmacotherapy of behavioral disorders in patients with dementia. Z Gerontol Geriatr 1999; 32: 153-158
267. Harvey R, Whithouse P, Rossor M. Report of the European Working Group on dementia drug guidelines meeting-Brussels, November 1997. Alzheimer Dis Assoc Disorders 1998; 12: 259-261
268. American Psychiatric Association. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. Am J Psychiatry 1997; 154: 1-39
269. Opie J, Rosewarne R, O'Connor D. The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review. Aust N Z J Psychiatr 1999; 33: 789-799
270. Spector A, Orrel M, Davies S, Woods B. Reality orientation for dementia (Cochrane Review). The Cochrane Library 2000
271. Hart BD, Wells DL. The effects of language used by caregivers on agitation in residents with dementia. Clin Nurse Spec 1997; 11: 20-23
272. Neal M, Briggs M. Validation therapy for dementia (Cochrane Review). The Cochrane Library 2000
273. Brotons M, Koger S, Pickett-Cooper P. Music and dementia: a review of the literature. Journal of Music Therapy 1997; 34: 204-245
274. Zarit SH, Gaugler JE, Jarrott SE. Useful services for families: research findings and directions. Int J Geriatr Psychiatry 1999; 14: 165-177
275. Trickey H, Harvey I, Wilcock G, Sharp D. Formal consensus and consultation: a qualitative method for development of a guideline for dementia. Qual Health Care 1998; 7: 192-199
276. Patterson CJ, Gauthier S, Bergman H, Cohen CA, Feightner JW, Feldman H, Hogan DB. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ 1999; 160: S1-15
277. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1972; 1: 233-238
278. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
279. Watson YI, Arfken CL, Birge SJ. Clock completion: an objective screening test for dementia. J Am Geriatr Soc 1993; 41: 1235-1240
280. Livingston G, Hinchliffe K. The epidemiology of psychiatric disorders in the elderly. Int Rev Psychiat 1993; 5: 317-326
281. MacDonald AJ. Do general practitioners "miss" depression in elderly patients? Br Med J (Clin Res Ed) 1986; 292: 1365-1367
282. Kessler D, Lloyd K, Lewis G, Gray DP. Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. BMJ 1999; 318: 436-439
283. Livingston G, Hawkins A, G raham N, Blizard B, Mann A. The Gospel Oak Study: prevalence rates of dementia, depression and activity limitation among elderly residents in inner London. Psychol Med 1990; 20: 137-146
284. Orrell M, Collins E, Shergill S, Katona C. Management of depression in the elderly by general practitioners: 1. Use of antidepressants. Fam Pract 1995; 12: 5-11
285. Old Age Depression Interest Group. How long should the elderly take antidepressants? A double-blind placebo controlled study of continuation/ prophylaxis therapy with Dothiepin. Br J Psychiat 1993; 162: 175-182
286. Chilvers C, Dewey M, Fielding K, Gretton V, Miller P, Palmer B, Weller D, Churchill R, Williams I, Bedi N, Duggan C, Lee A, Harrison G. Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ 2001; 322: 772-775
287. NIH Consensus Development Panel on Depression in Late Life. Diagnosis and treatment of depression in late life. JAMA 1992; 266: 1018-1024
288. Lebowitz BD, Pearson JL, Schneider LS. Diagnosis and treatment of depression in late life. JAMA 1997; 278: 14
289. Rubenstein LV, Calkins DR, Greenfield S, Jette AM, Meenan RF, Nevins MA, Rubenstein LZ, Wasson JH, Williams ME. Health status assessment for elderly patients. Report of the Society of General Internal Medicine Task Force on Health Assessment. J Am Geriatr Soc 1989; 37: 562-569
290. WHO. International classification of impairments, disabilities and handicaps. WHO, Geneva, 1980
291. Royal College of Physicians and the British Geriatric Society. Standardised assessment scales for elderly people. Royal College of Physicians, London, and the British Geriatric Society, London, 1992
292. Carpenter GI, Demopoulos GR. Screening the elderly in the community: controlled trial of dependency surveillance using a questionnaire administered by volunteers. BMJ 1990; 300: 1253-1256
293. Rubenstein LV, Calkins DR, Young RT, Cleary PD, Fink A, Kosecoff J, Jette AM, Davies AR, Delbanco TL, Brook RH. Improving patient function: a randomized trial of functional disability screening. Ann Intern Med 1989; 111: 836-842
294. McVey LJ, Becker PM, Saltz CC, Feussner JR, Cohen HJ. Effect of a geriatric consultation team on functional status of elderly hospitalized patients. A randomized, controlled clinical trial. Ann Intern Med 1989; 110: 79-84
295. Wahl HW. Decline of competence in aging: an evaluation of the literature on "activities of daily living" and need for nursing care. Z Gerontol 1993; 26: 366-377
296. Stuck AE, Walthert JM, Nikolaus T, Bula CJ, Hohmann C, Beck JC. Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med 1999; 48: 445-469
297. Charlton JR, Patrick DL, Peach H. Use of multivariate measures of disability in health surveys. J Epidemiol Community Health 1983; 37: 296-304
298. Nelson E, Wasson J, Kirk J et al. Assessment of function in routine clinical practice: description of the COOP Chart method and preliminary findings. J Chron Dis 1987; 40: 55S-63S(Suppl 1
299. Van Weel C, König-Zahn C, Touw-Otten FWMM. Measuring Functional Health with the COOP/WONCA charts: a manual. Groningen, Northern Centre of Health Care Research, 1995
300. Townsend P. Poverty in the United Kingdom Penguin Books, Harmondsworth, 1978
301. van Oostrom MA, Tijhuis MA, de Haes JC, Tempelaar R, Kromhout D. A measurement of social support in epidemiological research: the social experiences checklist tested in a general population in The Netherlands. J Epidemiol Community Health 1995; 49: 518-524
302. Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol Bull 1985; 98: 310-357
303. House JS, Umberson D, Landis KR. Structures and processes of social support. Ann Rev Sociol 1988; 14: 293-318
304. Berkman LF. The assessment of social networks and social support in the elderly. J Am Geriatr Soc 1983; 31: 743-749
305. Penninx B. Social support in elderly people with chronic disease. Does it really help? (Thesis). Free University, Amsterdam, 1996
306. Bowling A. Social support and social networks: their relationship to the successful and unsuccessful survival of elderly people in the community. An analysis of concepts and a review of the evidence. Fam Pract 1991; 8: 68-83
307. Merrill DM. Caring for elderly patients: juggling work, family, and care giving in middle and working class. Auburn House, London, 1997
308. Dooghe G. The aging of the population in Europe. Socioeconomic characteristics of the elderly population. Garant Publishers, Leuven-Kessel-Lo, Belgium, 1992
309. Cartwright A, Smith C. Elderly people, their medicine, and their doctors. Routledge, London, 1988
310. Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing 1980; 9: 73-80
311. Royal College of Physicians Working Party. Medication for the elderly. J R Coll Phys London 1984; 18: 7-17
312. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-1195
313. Hallas J, Harvald B, Worm J et al. Drug related hospital admission. Results from an intervention program. Eur J Clin Pharmacol 1990; 38: 315-318
314. Agner E. Smoking and health in old age. A ten-year follow-up study. Acta Med Scand 1985; 218: 311-316
315. Mattson ME, Pollack ES, Cullen JW. What are the odds that smoking will kill you? Am J Public Health 1987; 77: 425-431
316. van de Mheen PJ, Gunning-Schepers LJ. Differences between studies in reported relative risks associated with smoking: an overview. Public Health Rep 1996; 111: 420-426
317. Haheim LL, Holme I, Hjermann I, Leren P. Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study. J Epidemiol Community Health 1996; 50: 621-624
318. Drings P. Tumorerkrankungen als Folge des Rauchens. Z Arztl Fortbild 1995; 89: 447-458
319. Hirsch A, Slama K, Alberisio A, Fowler G, Lagrue G, Malvezzi I, Manley M, Molimard R, Tonnesen P. Smoking cessation methods: recommendations for health professionals. Advisory Group of the European School of Oncology. Eur J Cancer 1994; 30A: 253-263
320. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994; 309: 901-911
321. Boyd NR. Smoking cessation: a four-step plan to help older patients quit. Geriatrics 1996; 51: 52-57
322. Richmond RL, Anderson P. Research in general practice for smokers and excessive drinkers in Australia and the UK. 1. Interpretation of results. Addiction 1994; 89: 35-40
323. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995; 155: 1933-1941
324. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994; 343: 139-142
325. Fagerstrom K. Measuring degree of physical dependence to tobacco smoking with reference to individualisation of treatment. Addictive Behaviour 1978; 3: 235-241
326. Bradley K. The primary care provider's role in the prevention and management of alcohol problems. Alcohol Health Res World 1994; 18: 87-104
327. Moore A, Hays R, Greendale G et al. Drinking habits among older persons: finding from the NHANES 1 Epidemiological follow up study (1982-84). JAGS 1999; 47: 412-416
328. Curtis JR, Geller G, Stokes EJ, Levine DM, Moore RD. Characteristics, diagnosis, and treatment of alcoholism in elderly patients. J Am Geriatr Soc 1989; 37: 310-316
329. Day C. Alcohol- risks and mechanisms of damage. J R Coll Phys 1994; 28: 254-259
330. Kannel W, Ellison R. Alcohol and coronary heart disease: the evidence for a protective effect. Clinica Chimica Acta 1996; 246: 59-76
331. Serdula MK, Koong SL, Williamson DF, Anda RF, Madans JH, Kleinman JC, Byers T. Alcohol intake and subsequent mortality: findings from the NHANES I Follow-up Study. J Stud Alcohol 1995; 56: 233-239
332. Selzer ML. The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 1971; 127: 1653-1658
333. Saunders JB, Aasland OG, Babor TF, Jr. de IF, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993; 88: 791-804
334. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984; 252: 1905-1907
335. Babor TF, Grant M, Acuda W, Burns FH, Campillo C, Del Boca FK, Hodgson R, Ivanets NN, Lukomskya M, Machona M. A randomized clinical trial of brief interventions in primary care: summary of a WHO project. Addiction 1994; 89: 657-660
336. Richmond R, Heather N, Wodak A, Kehoe L, Webster I. Controlled evaluation of a general practice-based brief intervention for excessive drinking. Addiction 1995; 90: 119-132
337. Aniansson A, Grimby G, Rundgren A, Svanborg A, Orlander J. Physical training in old men. Age Ageing 1980; 9: 186-187
338. Cress ME, Buchner DM, Questad KA, Esselman PC, deLateur BJ, Schwartz RS. Exercise: effects on physical functional performance in independent older adults. J Gerontol A Biol Sci Med Sci 1999; 54: M242-M248
339. Jr. Ettinger WH, Burns R, Messier SP, Applegate W, Rejeski WJ, Morgan T, Shumaker S, Berry MJ, O'Toole M, Monu J, Craven T. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis: The Fitness Arthritis and Seniors Trial (FAST). JAMA 1997; 277: 25-31
340. Singh NA, Clements KM, Fiatarone MA. A randomized controlled trial of progressive resistance training in depressed elders. J Gerontol A Biol Sci Med Sci 1997; 52: M27-M35
341. Elward K, Larson EB. Benefits of exercise for older adults. A review of existing evidence and current recommendations for the general population. Clin Geriatr Med 1992; 8: 35-50
342. Eaton CB, Menard LM. A systematic review of physical activity promotion in primary care office settings. Br J Sports Med 1998; 32: 11-16
343. Eakin EG, Glasgow RE, Riley KM. Review of primary care-based physical activity intervention studies: effectiveness and implications for practice and future research. J Fam Pract 2000; 49: 158-168
344. Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM. Falls prevention over 2 years: a randomized controlled trial in women 80 years and older. Age Ageing 1999; 28: 513-518
345. Glass TA, de Leon CM, Marottoli RA, Berkman LF. Population based study of social and productive activities as predictors of survival among elderly Americans. BMJ 1999; 319: 478-483
346. Cupples ME, McKnight A. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. BMJ 1994; 309: 993-996
347. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ 1994; 308: 313-320
348. Ebrahim S, Smith GD. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ 1997; 314: 1666-1674
349. Thorogood 2000. Changing behaviour. Clinical evidence. A compendium of the best available evidence for effective health care. BMJ Publishing Group, London, 2000
350. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 1996; 156: 745-752
351. Lachs M, Feinstein A, Cooney A et al. A simple procedure for general screening for functional disability in elderly patients. Ann Int Med 1990; 112: 699-706
352. Gallo JJ, Reichel W, Anderson LM. Handbook of geriatric assessment. Aspen-Publishers, Gaithersburg, Maryland, 1995
353. Barberger-Gateau P, Chaslerie A, Dartigues JF, Commenges D, Gagnon M, Salamon R. Health measures correlates in a French elderly community population: the PAQUID study. J Gerontol 1992; 47: S88-S95
354. Barberger-Gateau P, Nejjari C, Tessier JF, Dartigues JF. Assessment of disability and handicap associated with dyspnoea in elderly subjects. Disabil Rehabil 1995; 17: 83-89
355. Stewart AL, Hays RD, Jr. Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26: 724-735
356. Gurland B, Kuriansky J, Sharpe L et al. The Comprehensive Assessment and Referral Evaluation (CARE): rationale, development and reliability. Int J Ageing Hum Dev 1977; 8: 9-42
357. Gurland B, Golden RR, Teresi JA, Challop J. The SHORT-CARE: an efficient instrument for the assessment of depression, dementia and disability. J Gerontol 1984; 39: 166-169
358. Fleming KC, Evans JM, Weber DC, Chutka DS. Practical functional assessment of elderly persons: a primary-care approach. Mayo Clin Proc 1995; 70: 890-910
359. Tinetti ME. personal communication. 2003
360. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977; 31: 42-48
361. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992; 45: 1101-1109
362. Sandvik H, Hunskaar S, Vanvik A, Bratt H, Seim A, Hermstad R. Diagnostic classification of female urinary incontinence: an epidemiological survey corrected for validity. J Clin Epidemiol 1995; 48: 339-343
363. Swan IR, Browning GG. The Whispered Voice as a Screening Test for Impairment. J Roy Coll Gen Pract 1985; 35: 197
364. Whooley MA, Avins AL, Miranda J, Browner WS. Case-Finding Instruments for Depression. J Gen Intern Med 1997; 12: 439-445
365. Shiekh JA, Yesavage JA. Geriatric Depression Scale (GDS): recent findings and developments of a shorter version. Clinical Gerontology: a guide to assessment and intervention. Howarth Press, New York, 1986
366. Qureshi KN, Hodkinson HM. Evaluation of a ten-question mental test in the institutionalized elderly. Age Ageing 1974; 3: 152-157
367. Hendriksen C. Preventive home visits to elderly patients. Status and perspectives. Geriatric Assessment Technology: The State of the Art. Editrice Kurtis, Milan, 1995: 231-237
368. Williams EI. Caring for Older People in the Community. Radcliffe Medical Press, Oxford, 1995
369. Stuck AE, Siu AL, Wieland GD, Adams J, Rubenstein LZ. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 1993; 342: 1032-1036
370. Tulloch AG, Moore V. A randomised controlled trial of geriatric screening and surveillance in general practice. J Roy Coll Gen Pract 1979; 29: 730-733
371. Stuck AE, Aronow HU, Steiner A, Alessi CA, Bula CJ, Gold MN, Yuhas KE, Nisenbaum R, Rubenstein LZ, Beck JC. A trial of annual in-home comprehensive geriatric assessments for elderly people living in the community. N Engl J Med 1995; 333: 1184-1189
372. Hay WI, van Ineveld C, Browne G, Roberts J, Bell B, Mills M, Chambers L, Gafni A, Macpherson S. Prospective care of elderly patients in family practice. Is screening effective? Can Fam Physician 1998; 44: 2677-2687
373. van Haastregt JC, Diederiks JP, van Rossum E, de Witte LP, Crebolder HF. Effects of preventive home visits to elderly people living in the community: systematic review. BMJ 2000; 320: 754-758
374. Vetter NJ, Jones DA, Victor CR. Effect of health visitors working with elderly patients in general practice: a randomised controlled trial. Br Med J (Clin Res Ed) 1984; 288: 369-372
375. Hendriksen C, Lund E, Stromgard E. Consequences of assessment and intervention among elderly people: a three year randomised controlled trial. Br Med J (Clin Res Ed) 1984; 289: 1522-1524
376. Sorensen KH. Follow-up three years after intervention to relieve unmet medical and social needs of old people. Compr Gerontol 1988; 2: 85-91
377. McEwan RT, Davison N, Forster DP, Pearson P, Stirling E. Screening elderly people in primary care: a randomized controlled trial. Br J Gen Pract 1990; 40: 94-97
378. Hall N, De Beck P, Johnson D et al. Randomised trial of a health promotion programme for frail elderly. Can J Age 1992; 72: 91
379. Pathy MS, Bayer A, Harding K, Dibble A. Randomised trial of case finding and surveillance of elderly people at home. Lancet 1992; 340: 890-893
380. Clarke M, Clarke SJ, Jagger C. Social intervention and the elderly: a randomized controlled trial. Am J Epidemiol 1992; 136: 1517-1523
381. van Rossum E, Frederiks CM, Philipsen H, Portengen K, Wiskerke J, Knipschild P. Effects of preventive home visits to elderly people. BMJ 1993; 307: 27-32
382. Fabacher D, Josephson K, Pietruszka F, Linderborn K, Morley JE, Rubenstein LZ. An in-home preventive assessment program for independent older adults: a randomized controlled trial. J Am Geriatr Soc 1994; 42: 630-638